Patient Access to Experimental Drugs and AIDS Clinical Trial Designs: Ethical Issues

Cambridge Quarterly of Healthcare Ethics 5 (3):400 (1996)
  Copy   BIBTEX

Abstract

Today's clinical AIDS research is in trouble. Principal investigators are confronted with young and frequently highly knowledgeable patients. Many of these people with AIDS are often unwilling to adhere to the trial protocols. These PWAs believe they are ethically justified in breaching trial protocols because they do not consider themselves true volunteers in such trials. PWAs argue that they do not really volunteer because existing legislation prevents them from buying and using experimental drugs or from testing alternative treatment strategies. Their only access to such agents is participation in clinical trials

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,386

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

AIDS: Bioethics and public policy.Udo Schuklenk - 2003 - New Review of Bioethics 1 (1):127-144.
Progress toward a more ethical method for clinical trials.Joseph B. Kadane - 1986 - Journal of Medicine and Philosophy 11 (4):385-404.

Analytics

Added to PP
2010-08-24

Downloads
36 (#432,773)

6 months
9 (#290,637)

Historical graph of downloads
How can I increase my downloads?

Author's Profile

Udo Schüklenk
Queen's University

Citations of this work

Philosophy, Drama and Literature.Rick Benitez - 2011 - In Graham Robert Oppy, Nick Trakakis, Lynda Burns, Steven Gardner & Fiona Leigh (eds.), A companion to philosophy in Australia & New Zealand. Clayton, Victoria, Australia: Monash University Publishing. pp. 371-372.
Justice in the Application of Science: Beyond Fair Benefits.Alex John London - 2010 - American Journal of Bioethics 10 (6):54-56.

Add more citations